Anthracimycin, a Potent Anthrax Antibiotic from a Marine-Derived Actinomycete
Anthracimycin, a Potent Anthrax Antibiotic from a Marine-Derived Actinomycete
复制标题
DOI:
10.1002/anie.201302749
复制
发表时间:
2013-07-22
影响因子:
16.6
通讯作者:
Fenical, William
中科院分区:
文献类型:
--
作者:
Jang, Kyoung Hwa;Nam, Sang-Jip;Fenical, William
The human infectious disease Anthrax is caused by the spore-forming, Gram-positive bacterium Bacillus anthracis. The disease, which is most common in those that handle infected farm animals, has also been used as a bioterrorism weapon. In 2001, just a week after the World Trade Center attacks, Anthrax was deliberately spread through the US postal system by sending letters with powdered B. anthracis spores. This caused 22 cases of Anthrax infection and ultimately claimed five lives.[1] Depending upon the method of exposure (inhalation of spores, direct bacterial contact, etc.) B. anthracis infections can require prolonged treatment often for 6 months with a variety of antibiotics. The pulmonary form of Anthrax is considered a medical emergency that may require continuous intravenous therapy with potent antibiotics. In a potential bioterrorism attack, individuals exposed to B. anthracis will be given antibiotics prior to onset of the illness. A vaccine has been developed but is not yet available to the general public.[2] Given the severity of this disease, and the fact that it can be spread by aerosol dispersal, the development of an effective arsenal of new antibiotics remains a high public priority.As a new, developing resource for microbial antibiotics, we have focused our efforts on marine microorganisms, particularly those that are in the deep oceans and specific to the marine environment. Examination of a Streptomyces species (our strain CNH365), isolated from near-shore marine sediments found near Santa Barbara, CA, showed that culture extracts possessed significant activity against B. anthracis and methicillin-resistant Staphylococcus aureus in broth dilution assays. Subsequent fractionation of the extract following antibacterial activities yielded a pure antibiotic, anthracimycin (1). Anthracimycin was isolated as a white solid that analyzed for the molecular formula C25H32O4 by HR-ESIMS analysis (− 0.2 mmu). The 13C NMR spectrum of 1 (Table 1) displayed what appeared to be two ketone functionalities, one ester or lactone group (δC 194.1, 190.9, and 168.9), nine methine carbon signals in the aromatic/olefinic region (δC 140~ 103), and an oxymethine